EC Number |
BRENDA No. |
Title |
Journal |
Volume |
Pages |
Year |
Organism |
PubMed ID |
---|
3.4.22.43 | 752418 |
Endostatin and cathepsin-V in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis |
Adv. Exp. Med. Biol. |
833 |
55-61 |
2015 |
Homo sapiens |
25252891 |
3.4.22.43 | 753828 |
Exogenous cathepsin V protein protects human cardiomyocytes HCM from angiotensin II-induced hypertrophy |
Int. J. Biochem. Cell Biol. |
89 |
6-15 |
2017 |
Homo sapiens |
28522343 |
3.4.22.43 | 753117 |
L-Homocysteine-induced cathepsin V mediates the vascular endothelial inflammation in hyperhomocysteinaemia |
Br. J. Pharmacol. |
175 |
1157-1172 |
2018 |
Homo sapiens |
28631302 |
3.4.22.43 | 752678 |
Melanosome degradation in epidermal keratinocytes related to lysosomal protease cathepsin V |
Biochem. Biophys. Res. Commun. |
500 |
339-343 |
2018 |
Homo sapiens |
29654760 |
3.4.22.43 | 753977 |
The Alkyne moiety as a latent electrophile in irreversible covalent small molecule inhibitors of cathepsin K |
J. Am. Chem. Soc. |
141 |
3507-3514 |
2019 |
Homo sapiens |
30689386 |
3.4.22.43 | 754753 |
The HIV protease inhibitor saquinavir inhibits HMGB1-driven inflammation by targeting the interaction of cathepsin V with TLR4/MyD88 |
Mol. Med. |
21 |
749-757 |
2015 |
Homo sapiens |
26349060 |
3.4.22.43 | 732867 |
A simple and efficient protocol for the production of recombinant cathepsin V and other cysteine cathepsins in soluble form in Escherichia coli |
Protein Expr. Purif. |
82 |
1-5 |
2012 |
Homo sapiens |
22100277 |
3.4.22.43 | 717374 |
Acridone alkaloids as potent inhibitors of cathepsin V |
Bioorg. Med. Chem. |
19 |
1477-1481 |
2011 |
Homo sapiens |
21277783 |
3.4.22.43 | 731213 |
Cathepsin L proteases of the parasitic copepod, Lepeophtheirus salmonis |
Aquaculture |
356-357 |
264-271 |
2012 |
Lepeophtheirus salmonis |
- |
3.4.22.43 | 137271 |
Cathepsin L2, a novel human cysteine proteinase produced by breast and colorectal carcinomas |
Cancer Res. |
58 |
1624-1630 |
1998 |
Homo sapiens |
9563472 |